Insulet (PODD) Q3 Earnings and Revenues Beat Estimates

Insulet (PODD) came out with quarterly earnings of $1.24 per share, beating the Zacks Consensus Estimate of$ 1.13 per share. This compares to earnings of $0.9 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +9.73%. A quarter ago, it was expected that this maker of insulin infusion systems would post earnings of$ 0.93 per share when it actually produced earnings of $1.17, delivering a surprise of +25.81%.Over the last four quar ...